8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 7, 2019

HILL-ROM HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Indiana (State or other jurisdiction of incorporation)	1-6651 (Commission File Number)	35-1160484 (IRS Employer Identification No.)
130 East Randolph Street Suite 1000 Chicago, IL (Address of principal executive offices)		60601 (Zip Code)
(312) 819-7200 (Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

☐ Emerging growth company (Indicate by check mark whether the registrant is an emerging growth company as defined in Rule

405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.b-2 of this chapter).

☐ If an emerging growth company, indicate by check mark of the registrant has elected not to use the extended transition period

for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 5.02.    DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS;

APPOINTMENT of CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN

OFFICERS.

On May 7, 2019, the Board of Directors (the “Board”) of Hill-Rom Holdings, Inc. (the “Company”) increased the size of the Board from 9 to 10 members and appointed Dr. Gregory J. Moore MD, PhD, to serve as director on the Board. The Board also appointed Dr. Moore a member of the Compensation and Management Development Committee. These actions were effective May 7, 2019.

In accordance with the Company’s non-employee director compensation program, as described in the Company’s proxy statement for its 2019 Annual Meeting of Shareholders under the caption “Director Compensation,” Dr. Moore is entitled to cash and equity compensation for service on the Board and the Compensation and Management Development Committee. There are no arrangements or understandings between Dr. Moore and any other persons pursuant to which Dr. Moore was named as a director. There are no transactions or relationships between the Company and Dr. Moore that are reportable under Item 404(a) of Regulation S-K.

Item 7.01.    REGULATION FD DISCLOSURE.

On May 7, 2019, the Company announced the appointment of Dr. Moore to the Board. A copy of the press release is furnished and attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of

Section 18 of the Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the

Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits.

99.1 Press Release of Hill-Rom Holdings, Inc. dated May 7, 2019

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		HILL-ROM HOLDINGS, INC.
		(Registrant)
DATE:  May 7, 2019	By:	/s/ Deborah M. Rasin
	Name: Title:	Deborah M. Rasin Senior Vice President Chief Legal Officer and Secretary

EX-99.1

Exhibit 99.1

CONTACT INFORMATION

Investor Relations

Contact:	Mary Kay Ladone, Senior Vice President, Corporate Development, Strategy and Investor Relations
Phone:	312-819-9387
Email:	MaryKay.Ladone@hill-rom.com
Media
Contact:	Howard Karesh, Vice President, Corporate Communications
Phone:	312-819-7268
Email:	Howard.Karesh@hill-rom.com

HILL-ROM ANNOUNCES APPOINTMENT OF

GREGORY MOORE TO BOARD OF DIRECTORS

CHICAGO, May 7, 2019 - Hill-Rom Holdings, Inc. (NYSE: HRC), announced the appointment of Gregory J. Moore MD, PhD, to its Board of Directors, effective May 7, 2019. Dr. Moore is currently the Corporate Vice President, Health Technology and Alliances at Microsoft Corporation.

“We are pleased to have an outstanding new addition to our board,” said William G. Dempsey, Hill-Rom’s Chair of the Board. “Greg’s breadth of leadership experience in the transformation of healthcare, and development and application of digital health technology will bring relevant  perspectives to Hill-Rom as the company pursues its vision of advancing connected care.”

Dr. Moore was previously Vice President Google Cloud Healthcare & Life Sciences. He is an engineer, practicing neuroradiologist and clinical informaticist, and holds a PhD from the Massachusetts Institute of Technology.

About Hill-Rom Holdings, Inc.

Hill-Rom is a leading global medical technology company with more than 10,000 employees worldwide. We partner with health care providers in more than 100 countries, across all care settings, by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Patient Monitoring and Diagnostics, Surgical Safety and Efficiency and Respiratory Health. Our innovations ensure caregivers have the products they need to help diagnose, treat and protect their patients; speed up recoveries; and manage conditions. Every day, around the world, we enhance outcomes for patients and their caregivers. Learn more at www.hill-rom.com.